Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: zolmitriptan

« Back to Dashboard

Zolmitriptan is the generic ingredient in three branded drugs marketed by Astrazeneca, Apotex Inc, Glenmark Generics, Zydus Pharms Usa Inc, Invagen Pharms, Mylan Pharms Inc, Sun Pharma Global, Teva Pharms Usa, and IPR, and is included in twelve NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for zolmitriptan. Five suppliers are listed for this compound.

Summary for Generic Name: zolmitriptan

Tradenames:3
Patents:2
Applicants:9
NDAs:12
Drug Master File Entries: see list20
Suppliers: see list5
Therapeutic Class:Antimigraine Agents

Clinical Trials for: zolmitriptan

Determine Central 5-HT1B Receptor Occupancy of ZOMIGĀ® Rapimelt (Zolmitriptan) in Healthy Male Volunteers
Status: Completed Condition: Migraine

ZAP, US. Zomig for Appropriate for Primary Care
Status: Completed Condition: Migraine

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Generics
ZOLMITRIPTAN
zolmitriptan
TABLET, ORALLY DISINTEGRATING;ORAL202560May 14, 2013RXNo<disabled><disabled>
Apotex Inc
ZOLMITRIPTAN
zolmitriptan
TABLET, ORALLY DISINTEGRATING;ORAL202476May 14, 2013RXNo<disabled><disabled>
Astrazeneca
ZOMIG-ZMT
zolmitriptan
TABLET, ORALLY DISINTEGRATING;ORAL021231Feb 13, 2001RXNo<disabled><disabled>
Astrazeneca
ZOMIG-ZMT
zolmitriptan
TABLET, ORALLY DISINTEGRATING;ORAL021231Sep 17, 2001RXYes<disabled><disabled>
Astrazeneca
ZOMIG
zolmitriptan
SPRAY;NASAL021450Sep 30, 2003RXYes6,750,237*PED<disabled>Y<disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc